Skip to main content
. 2026 Aug 17;14(8):706. doi: 10.3390/vaccines14080706
COVID-19 Coronavirus Disease 2019
mRNA Messenger ribonucleic acid
AIRDs Autoimmune inflammatory rheumatic diseases
EULAR European Alliance of Associations for Rheumatology
SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2
PV Pharmacovigilance
VAERS Vaccine Adverse Event Reporting System
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
ICTPR International Clinical Trials Registry Platform
STROBE Strengthening the Reporting of Observational Studies in Epidemiology
READUS-PV Reporting of Evidence-based Disproportionality Analyses for Pharmacovigilance
ROBINS-I Risk Of Bias In Non-randomized Studies-of Interventions
RoB2 Risk of Bias 2
RCT Randomised controlled trials
ROR Reporting odds ratio
PRR Proportional reporting ratio
IC Information component
SLE Systemic lupus erythematosus